All the News That's Fun to Print

By Sarah Greene All the News That’s Fun to Print Scientific dialogue and that in the popular press can diverge radically. Why not explain that natural selection has already “engineered” the most invidious creatures imaginable? It’s a fun time to be a biologist. The Science paper from the J. Craig Venter Institute on reengineering a Mycoplasma cell using the techniques of synthetic biology stole the media spotlight for several wee

Written bySarah Greene
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

It’s a fun time to be a biologist. The Science paper from the J. Craig Venter Institute on reengineering a Mycoplasma cell using the techniques of synthetic biology stole the media spotlight for several weeks in May and June, and will likely be debated in blogs, tweets, and podcasts for many months to come. The first evaluation delivered in Faculty of 1000 deemed it “exceptional” and “proof of concept,” further suggesting it would initiate interesting scientific and philosophical discussions. Indeed, the discourse among thought leaders in Nature, Edge, and other science publications has been thoughtful and far reaching—a journal club on steroids.

1st cell with synthetic genome

Warming extinguishing lizards

Thought experiment: Is the synthetic cell about life?

Whether or not this is just about tools, as some have suggested, or a major discovery, as others propose (see the quote by Freeman Dyson on page 18), the achievement of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies